What is the equity of Aptinyx this year?
Aptinyx has equity of 38.3 M USD this year.
Aptinyx Equity 2024
Aptinyx Equity
38.3 M USD
Ticker
APTX
ISIN
US03836N1037
WKN
A2JPB1
In 2024, Aptinyx's equity was 38.3 M USD, a -59.6% increase from the 94.8 M USD equity in the previous year.
Aptinyx Aktienanalyse
What does Aptinyx do?
Aptinyx Inc is a biopharmaceutical company specializing in the development of therapies for the treatment of neurological diseases. The company was founded in 2015 in Evanston, Illinois, USA, and has since achieved an impressive track record in researching and developing innovative therapies. The history of Aptinyx Inc begins with a group of experienced scientists and researchers who came together to push the boundaries of neuroscience research and discover new treatment options for people with brain disorders. The company is based on the belief that the human brain is a fascinating and complex entity that still holds many secrets. The company is committed to improving human well-being through innovative neurotherapeutic products and services. Aptinyx Inc's business model focuses on the research, development, and commercialization of novel therapeutic treatments for neurological diseases. The company closely collaborates with leading academic institutions and facilities to leverage the best research findings and methods. The company has a strong scientific foundation led by an experienced team of researchers and developers working on innovative biomarker and therapy strategies. Aptinyx Inc has focused on the development of neuromodulators and neuroprotectants to treat neurological diseases, including pain disorders, peripheral neuropathies, neuropathic pain, Parkinson's disease, post-traumatic stress disorder (PTSD), and other central nervous system disorders. Aptinyx Inc's products are based on a comprehensive understanding of the fundamentals of the nervous system and how it functions. The company offers a variety of products and services, including novel therapeutics for the treatment of pain, neuropathy, and other neurological diseases. These products are based on the utilization of Aptinyx's proprietary technologies to selectively modulate specific cell types and signaling pathways in the nervous system. The products and services of Aptinyx Inc have been regulated by leading health authorities in the US and Europe. Aptinyx Inc has two main divisions of products: the first focus is on the development of neuromodulators that specifically alleviate pain and modulate the brain. The second focus is on the development of neuroprotectants that help protect neurons and reduce inflammation in the nervous system. These two divisions are closely interconnected as they are based on a common platform grounded in the exploration of novel biomarkers and therapeutic targets. The products of Aptinyx Inc are designed for both pain relief and improvement of neural functions. Additionally, these products aim to enhance patient experience and quality of life. The company consistently collaborates with potential partners and experts to develop products tailored to the needs of patients and healthcare providers. Overall, Aptinyx Inc has revolutionized the world of neuroscience by exploring and developing innovative solutions for neurological diseases. The company has achieved an impressive track record by utilizing its scientific expertise and groundbreaking technologies to set new trends in neuroscience research and therapeutics. In summary, Aptinyx Inc has developed a unique approach to the development of neuromodulators and neuroprotectants based on a deep understanding of the structure and function of the nervous system. The products and services of the company have the potential to play a significant role in improving the quality of life for patients with neurological diseases. Aptinyx ist eines der beliebtesten Unternehmen auf Eulerpool.com.Equity Details
Analyzing Aptinyx's Equity
Aptinyx's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Aptinyx's equity is essential for assessing its financial health, stability, and value to shareholders.
Year-to-Year Comparison
Evaluating Aptinyx's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Impact on Investments
Aptinyx's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Interpreting Equity Fluctuations
Fluctuations in Aptinyx’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Frequently Asked Questions about Aptinyx stock
What was the equity of Aptinyx compared to the previous year?
The equity of Aptinyx has increased/decreased by -59.6% decreased compared to the previous year.
What impact does a high equity have on investors of Aptinyx?
A high equity is advantageous for investors of Aptinyx as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
What impact does low equity have on investors of Aptinyx?
A low equity can be a risk for investors of Aptinyx, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
How does an increase in equity of Aptinyx affect the company?
An increase in equity of Aptinyx can strengthen the company's financial position and improve its ability to make investments in the future.
How does a reduction in the equity of Aptinyx affect the company?
A reduction in equity of Aptinyx can affect the financial situation of the company and lead to a higher dependence on debt capital.
What are some factors that influence the equity of Aptinyx?
Some factors that can affect the equity of Aptinyx include profits, dividend payments, capital increases, and acquisitions.
Why is the equity of Aptinyx so important for investors?
The equity of Aptinyx is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
What strategic measures can Aptinyx take to change the equity?
To change equity, Aptinyx can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
How much dividend does Aptinyx pay?
Over the past 12 months, Aptinyx paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Aptinyx is expected to pay a dividend of 0 USD.
What is the dividend yield of Aptinyx?
The current dividend yield of Aptinyx is .
When does Aptinyx pay dividends?
Aptinyx pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Aptinyx?
Aptinyx paid dividends every year for the past 0 years.
What is the dividend of Aptinyx?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Aptinyx located?
Aptinyx is assigned to the 'Health' sector.
Wann musste ich die Aktien von Aptinyx kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Aptinyx from 12/29/2023 amounting to 0.099 USD, you needed to have the stock in your portfolio before the ex-date on 1/2/2024.
When did Aptinyx pay the last dividend?
The last dividend was paid out on 12/29/2023.
What was the dividend of Aptinyx in the year 2023?
In the year 2023, Aptinyx distributed 0 USD as dividends.
In which currency does Aptinyx pay out the dividend?
The dividends of Aptinyx are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Aptinyx
Our stock analysis for Aptinyx Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Aptinyx Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
